Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.

Hirano T, Tatetsu H, Ueno S, Shichijo T, Nakamura T, Yamada A, Uchiba M, Kato K, Nosaka K, Matsuoka M, Yasunaga JI

DOI: 10.1002/cnr2.70413
Published: 2025 Dec
Container: Cancer reports (Hoboken, N.J.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cnr2.70413,
  title = {Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.},
  author = {Hirano T and Tatetsu H and Ueno S and Shichijo T and Nakamura T and Yamada A and Uchiba M and Kato K and Nosaka K and Matsuoka M and Yasunaga JI},
  year = {2025},
  journal = {Cancer reports (Hoboken, N.J.)},
  doi = {10.1002/cnr2.70413},
  url = {https://doi.org/10.1002/cnr2.70413}
}

RIS

TY  - JOUR
TI  - Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.
AU  - Hirano T
AU  - Tatetsu H
AU  - Ueno S
AU  - Shichijo T
AU  - Nakamura T
AU  - Yamada A
AU  - Uchiba M
AU  - Kato K
AU  - Nosaka K
AU  - Matsuoka M
AU  - Yasunaga JI
PY  - 2025
JO  - Cancer reports (Hoboken, N.J.)
DO  - 10.1002/cnr2.70413
UR  - https://doi.org/10.1002/cnr2.70413
ER  -

APA

T, H., H, T., S, U., T, S., T, N., A, Y., M, U., K, K., K, N., M, M., & JI, Y. (2025). Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.. Cancer reports (Hoboken, N.J.). https://doi.org/10.1002/cnr2.70413

Source records

pubmed · retrieved 2026-09-27T00:39:09.169Z